Your browser doesn't support javascript.
In severe COVID-19, adding lopinavir-ritonavir to usual care did not improve mortality at 28 days.
Singh, Ameeta.
  • Singh A; University of Alberta, Edmonton, Alberta, Canada (A.S.).
Ann Intern Med ; 174(1): JC3, 2021 01.
Article in English | MEDLINE | ID: covidwho-1518748
Semantic information from SemMedBD (by NLM)
1. lopinavir / ritonavir TREATS Patients
Subject
lopinavir / ritonavir
Predicate
TREATS
Object
Patients
2. lopinavir / ritonavir TREATS Patients
Subject
lopinavir / ritonavir
Predicate
TREATS
Object
Patients

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Ritonavir / Lopinavir / COVID-19 / Hospitalization Subject: Antiviral Agents / Ritonavir / Lopinavir / COVID-19 / Hospitalization Type of study: Controlled clinical trial Language: English Journal: Ann Intern Med Clinical aspect: Therapy Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Ritonavir / Lopinavir / COVID-19 / Hospitalization Subject: Antiviral Agents / Ritonavir / Lopinavir / COVID-19 / Hospitalization Type of study: Controlled clinical trial Language: English Journal: Ann Intern Med Clinical aspect: Therapy Year: 2021
...